Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AbstractAmong synthetic vaccines, virus‐like particles (VLPs) are used for their ability to induce strong humoral responses. Very little is reported on VLP‐based‐vaccine‐induced CD4+ T‐cell responses, despite the requirement of helper T cells for antibody isotype switching. Further knowledge on helper T cells is also needed for optimization of CD8+ T‐cell vaccination. Here, we analysed human CD4+ T‐cell responses to vaccination with MelQbG10, which is a Qβ‐VLP covalently linked to a long peptide derived from the melanoma self‐antigen Melan‐A. In all analysed patients, we found strong antibody responses of mainly IgG1 and IgG3 isotypes, and concomitant Th1‐biased CD4+ T‐cell responses specific for Qβ. Although less strong, comparable B‐ and CD4+ T‐cell responses were also found specific for the Melan‐A cargo peptide. Further optimization is required to shift the response more towards the cargo peptide. Nevertheless, the data demonstrate the high potential of VLPs for inducing humoral and cellular immune responses by mounting powerful CD4+ T‐cell help.

More information Original publication

DOI

10.1002/eji.201142064

Type

Journal article

Publisher

Wiley

Publication Date

2012-02-01T00:00:00+00:00

Volume

42

Pages

330 - 340

Total pages

10